Abstract
Merkel cell carcinoma (MCC) is a rare type of skin cancer. It is the first human cancer known to be associated with a polyomavirus. The vast majority of publications are case reports. Our goal is to discuss practical suggestions for the treatment, based on our clinical experience and a review of the literature. Surgery is the initial treatment of choice. Radiotherapy is used as primary or adjuvant treatment. The chemotherapeutic approach follows that of neuroendocrine neoplasms, using cisplatin and etoposide. Researchers are looking into other active drugs which have been used for melanoma including temozolomide, and PD-1 inhibitors. Scientists are studying mutations in MCC to identify potential targets for more effective systemic treatments. We hope this review will be useful for clinicians to apply current principles and provide food for thought to improve treatment outcomes.
Keywords: Chemotherapy, polyomavirus, radiotherapy, surgery.
Current Cancer Therapy Reviews
Title:Merkel Cell Carcinoma – Current State and the Future
Volume: 12 Issue: 2
Author(s): Patricia Tai, Khanh Vu, Vamsee Torri, Derek Suderman and Arbind Dubey
Affiliation:
Keywords: Chemotherapy, polyomavirus, radiotherapy, surgery.
Abstract: Merkel cell carcinoma (MCC) is a rare type of skin cancer. It is the first human cancer known to be associated with a polyomavirus. The vast majority of publications are case reports. Our goal is to discuss practical suggestions for the treatment, based on our clinical experience and a review of the literature. Surgery is the initial treatment of choice. Radiotherapy is used as primary or adjuvant treatment. The chemotherapeutic approach follows that of neuroendocrine neoplasms, using cisplatin and etoposide. Researchers are looking into other active drugs which have been used for melanoma including temozolomide, and PD-1 inhibitors. Scientists are studying mutations in MCC to identify potential targets for more effective systemic treatments. We hope this review will be useful for clinicians to apply current principles and provide food for thought to improve treatment outcomes.
Export Options
About this article
Cite this article as:
Tai Patricia, Vu Khanh, Torri Vamsee, Suderman Derek and Dubey Arbind, Merkel Cell Carcinoma – Current State and the Future, Current Cancer Therapy Reviews 2016; 12 (2) . https://dx.doi.org/10.2174/1573394712666160921153207
DOI https://dx.doi.org/10.2174/1573394712666160921153207 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics
The thematic issue will focus on key areas such as lipid nanoparticles, mRNA therapeutics, drug delivery systems, nanotechnology in medicine, targeted therapy, non-viral vectors, precision medicine, and biomedical engineering.read more
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanomedicinal Approach of Getting Across the Brood-Brain Barrier with Nanomedicinal Nanoparticles
Current Medicinal Chemistry SNAP-Tag Technology: A Powerful Tool for Site Specific Conjugation of Therapeutic and Imaging Agents
Current Pharmaceutical Design How Much of the Proteome Do We See with Discovery-Based Proteomics Methods and How Much Do We Need to See?
Current Proteomics A Comparative Study of Glucose and Fructose in the Development of Sarcoma 180 in Mice
Letters in Organic Chemistry Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Current Drug Targets Pathogenesis of HIV-Associated Non-Hodgkin Lymphoma
Current HIV Research Pixuvri<sup>®</sup> (Pixantrone Dimaleate, BBR 2778): From Lab to Market
Current Organic Chemistry Tumor-Induced Alterations in Lipid Metabolism
Current Medicinal Chemistry Chemotypic Variation of Lupeol in Roots of Hemidesmus indicus (L.) R.Br. from Different Agroclimatic Regions of Madhya Pradesh State of India
Current Traditional Medicine Systematic Evaluation of Drug-Loaded Hydrogels for Application in Osteosarcoma Treatment
Current Pharmaceutical Biotechnology Polyphenols Counteract Tumor Cell Chemoresistance Conferred by Multidrug Resistance Proteins
Anti-Cancer Agents in Medicinal Chemistry Natural Products Inhibiting the Ubiquitin-Proteasome Proteolytic Pathway, A Target for Drug Development
Current Medicinal Chemistry A Link Between Chemical Structure and Biological Activity in Triterpenoids
Recent Patents on Anti-Cancer Drug Discovery Polyphenols: Skin Photoprotection and Inhibition of Photocarcinogenesis
Mini-Reviews in Medicinal Chemistry Preliminary Studies on the Activity of Mixed Polyphenol-Heterocyclic Systems Against B16-F10 Melanoma Cancer Cells
Medicinal Chemistry A Wnt-ow of Opportunity: Targeting the Wnt/β-Catenin Pathway in Breast Cancer
Current Drug Targets The Role of Flavonoids in Inhibiting IL-6 and Inflammatory Arthritis
Current Topics in Medicinal Chemistry Heparanase as a Target in Cancer Therapy
Current Cancer Drug Targets Salidroside - Can it be a Multifunctional Drug?
Current Drug Metabolism Matching Chelators to Radiometals for Positron Emission Tomography Imaging- Guided Targeted Drug Delivery
Current Drug Targets